The influence of cigarette smoking on cytokine levels in patients with Inflammatory Bowel Disease

Inflammatory Bowel Diseases

Volumn 5, Issue 2, 1999, Pages 73-78

  Sher, Marc E ^a   Bank, Simmy ^b   Greenberg, Ronald ^b   Sardinha, T Cristina ^a   Weissman, Sam ^b   Bailey, Beverly ^b   Gilliland, Robert ^a   Wexner, Steven D ^a  

^a DEPARTMENT OF COLORECTAL SURGERY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

Cigarette smoking; Cytokines; Inflammatory bowel disease

Indexed keywords

INTERLEUKIN 8; INTERLEUKIN DERIVATIVE;

ARTICLE; CASE CONTROL STUDY; CHEMISTRY; COLON; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; INTESTINE MUCOSA; SMOKING; ULCERATIVE COLITIS;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-8; INTERLEUKINS; INTESTINAL MUCOSA; SMOKING;

EID: 0033129981     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1097/00054725-199905000-00001     Document Type: Article

References (34)

1. Harries AD, Baird A, Rhodes J. Nonsmoking: a feature of ulcerative colitis. BMJ 1982;284:706.
2. Logan RF, Edmond M, Somerville KW, Langman MJ. Smoking and ulcerative colitis. BMJ 1984;288:751-3.
3. Motley RJ, Rhodes J, Kay S, Morris TJ. Late presentation of ulcerative colitis in ex-smokers. Im J Colorectal Dis 1988;3: 171-5.
4. Perrson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke: a case control study. Gut 1990;31:1377-81.
5. Motley RJ, Rhodes J, Ford GA et al. Time relationships between cessation of smoking and onset of ulcerative colitis. Digestion 1987;37:125-7.
6. Pullan RD, Rhodes J, Ganesh S, et al. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-5.
7. Sartor RB. Pathogenetic and clinical relevance of cytokines in inflammatory bowel disease. Immunol Res 1991;10:465-71.
8. Brynskov J, Nielsen OH, Ahnefelt-Rohne I, Bendtzen K. Cytokines in inflammatory bowel disease. Scand J Gastroenterol 1992; 27:897-906.
9. Sher ME, D'Angelo AJ, Stein TA, Bailey B, Burns G, Wise L. Cytokines in Crohn's colitis. Am J Surg 1995;169:133-6.
10. Fiocchi C. Cytokines and animal models: a combined path to inflammatory bowel disease pathogenesis. Gastroenterology 1993; 104:1207-19.
11. Mahida YR, Wu K, Jewell DP. Enhanced production of Interleukin-1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989;30:835-8.
12. Miller LG, Goldstein G, Murphy M, Ginns LC. Reversible alterations in immunoregulatory T-cells in smoking: analysis by monoclonal antibodies and flow cytometry. Chest 1982;82:526-9.
13. Person M, Edwards AE, Lind A, Milton GW, Hersey P. Low natural killer cells activity and immunoglobulin levels associated with smoking in human subjects. Int J Cancer 1979;23:603-9.
14. Izzo RS, Witkon K, Chen AI, et al. Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease. Scand J Gastroenterol 1993;28:296-300.
15. Mahida YR, Ceska M, Effenberger F, et al. Enhanced synthesis of neutrophil-activating peptide-1/Interleukin-8 in active ulcerative colitis. Clin Sci 1992;82:273-5.
16. Brynskov J, Tvede N, Anderson CB, Vilien M. Increased concentrations of interleukin-1-beta, interleukin-2, and soluble interleukin-2 receptors in endoscopic mucosal biopsy specimens with active inflammatory bowel disease. Gut 1992;33:55-8.
17. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-4.
18. Gross V, Andos T, Caesar I, et al. Evidence of continuous stimulation of interleukin-6 production in Crohn's disease. Gastroenterology 1992;102:514-9.
19. Mullin GE, Lazenby AJ, Harris ML, et al. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not in ulcerative colitis. Gastroenterology 1992;102: 1620-27.
20. Nassif A, Longo W, Mazuski, Vernava AM, Kaminski DL. Role of cytokines and platelet activating factor in inflammatory bowel disease: implications for therapy. Dis Colon Rectum 1996;39:217-23.
21. Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double blind, randomized trial of cyclosporin therapy in active chronic Crohn's disease. N Engl J Med 1989;321:845-50.
22. Smith MB, Lashner BA, Hanauer SB. Smoking and inflammatory bowel disease in families. Am J Gastroenterol 1988;83:407-9.
23. Benoni C, Nilsson A, Nived O. Smoking and inflammatory bowel disease: comparison with systemic lupus erythematosus. Scan J Gastroenterol 1990;25:751-5.
24. Silverstein MD, Lashner BA, Hanauer SB. Cigarette smoking and ulcerative colitis: A case-controlled study. Mayo Clinic Proc 1994; 69:425-9.
25. Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987;93:316-21.
26. Srivastava ED, Russell MA, Feyerabend C, Rhodes J. Effect of ulcerative colitis and smoking on rectal blood flow. Gut 1990;31: 1021-4.
27. Zijlstra FJ, Srivastava ED, Rhodes M, et al. Effect of nicotine on rectal mucus and mucosal eicosanoids. Gut 1994;35:247-51.
28. Klein O, Colombel JF, Lescut D, et al. Remaining small bowel endoscopic lesions at surgery have no influence on early anastomotic recurrences in Crohn's disease. Am J Gastrenterol 1995;90: 1949-52.
29. Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL1-beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
30. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98:1123-8.
31. Van Dijk JP, Madretsma GS, Keuskamp ZJ, et al. Nicotine inhibits cytokine synthesis by mouse colonic mucosa. Eur J Pharmacol 1995;278:R11-R12.
32. Madretsma GS, Donze GJ, van Dijk AP, et al. Nicotine inhibits the production of interleukin 2 and tumour necrosis factor alpha by human mononuclear cells. Immunopharmacology 1995;35:47-51.
33. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's disease CA2 study group. N Engl J Med 1997;337:1029-35.
34. Nikolaus S, Bauditz J, Gionchetti P, et al. Increased secretion of proinflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut 1988;42:470-6.